Arnold Lippa

Arnold Lippa appears in our data through filings on RespireRx Pharmaceuticals Inc. shares, published by SEC (Form 4). In total, 5 filings cover trades dated from 14 April 2014 to 22 March 2020.

No open-market sale appears; the market trades are 1 purchase. The totals do not cover 1 filing with an undisclosed amount. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Outside the open market, there are 1 share grant.

On 24 March 2020 came the latest disclosure, a transaction in RespireRx Pharmaceuticals Inc. The last purchase on record was published on 14 September 2018, which is 2,961 days ago. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.